Dennis D Kim Cyma Bay Therapeutics, Inc. (CBAY) insider trading activity

Dennis D Kim is Chief Medical Officer of CymaBay Therapeutics, Inc.. Currently has a direct ownership of 20,000 shares of CBAY, which is worth approximately $0. The most recent transaction as insider was on Apr 17, 2023, when has been sold 112,219 shares (Common Stock) at a price of $9.54 per share, resulting in proceeds of $1,070,569. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20K

0% 3M change

0% 12M change

Total Value Held $0

DENNIS D KIM Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 17 2023	SELL Open market or private sale	$1,070,569 $9.54 p/Share	112,219 Reduced 84.87%	20,000 Common Stock
Apr 17 2023	BUY Exercise of conversion of derivative security	$490,397 $4.37 p/Share	112,219 Added 45.91%	132,219 Common Stock
Apr 13 2023	SELL Open market or private sale	$69,873 $8.98 p/Share	7,781 Reduced 28.01%	20,000 Common Stock
Apr 13 2023	BUY Exercise of conversion of derivative security	$34,002 $4.37 p/Share	7,781 Added 21.88%	27,781 Common Stock
Mar 28 2023	SELL Open market or private sale	$898 $8.98 p/Share	100 Reduced 0.5%	20,000 Common Stock
Mar 28 2023	BUY Exercise of conversion of derivative security	$437 $4.37 p/Share	100 Added 0.5%	20,100 Common Stock
Jan 19 2022	BUY Open market or private purchase	$60,800 $3.04 p/Share	20,000 Added 50.0%	20,000 Common Stock

DDK

Dennis D Kim

Chief Medical Officer

Newark, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CBAY shares.

Notify only if

Value

Insider Trading

Get notified when an Cyma Bay Therapeutics, Inc. insider buys or sells CBAY shares.

Notify only if

Operation

Value

Type

News

Receive news related to CymaBay Therapeutics, Inc.

Track Activities on CBAY

Account